Table 4

Patient expectation on treatment targets

Outcome to avoidMinimum level of risk to agree to this target (%)Patient numbers (accumulative percentage)Minimum level of risk reduction benefit to agree to this target (%)Patient numbers (accumulative percentage)
Flare during next year








1051 (18.4)1053 (19.1)
2023 (26.7)2567 (43.3)
3032 (38.3)50103 (81.9)
4013 (43.0)9050 (100.0)
5081 (72.2)
6018 (78.7)
7017 (84.8)
8023 (93.1)
907 (95.7)
10012 (100.0)
Hospitalisation during next 1 year








1085 (29.6)1081 (31.1)
2033 (41.1)2562 (47.8)
3034 (53.0)5095 (79.6)
4010 (56.4)9061 (100.0)
5054 (75.3)
6012 (79.4)
7014 (84.2)
8015 (89.5)
906 (91.6)
10024 (100.0)
IBD-surgery during next 5 years








10106 (37.2)1090 (38.1)
2031 (48.1)2550 (50.2)
3024 (56.5)5087 (79.3)
4011 (60.4)9062 (100.0)
5049 (77.5)
609 (80.7)
7011 (84.6)
8012 (88.8)
908 (91.6)
10024 (100.0)
Colorectal cancer during next 20 years








10124 (42.6)10110 (39.5)
2031 (53.3)2550 (53.5)
3032 (64.3)5084 (81.6)
409 (67.4)9055 (100.0)
5047 (83.5)
608 (86.3)
703 (87.3)
8013 (91.8)
904 (93.1)
10020 (100.0)